Pharmaceutical synthesis generates more waste per kilogram of product than almost any other industry. Traditional chemistry cleans up afterwards; green chemistry redesigns the equation itself. Add more steps and watch the waste pile up as a route gets longer.
Atom economy measures what fraction of all reactant atoms end up in your desired product. Traditional synthesis stacks reagents that achieve the transformation but leave molecular debris behind: protecting groups, stoichiometric oxidants, coupling agents that become side-products. Green chemistry asks: can you design a reaction where every atom you add lands in the final molecule? In the picture each step keeps 60% of the mass and the losses multiply: four steps keep 0.6 × 0.6 × 0.6 × 0.6, about 13%, and one step keeps 60%. Catalytic routes do better still, because the catalyst cycles back and is not part of the waste; a well-designed catalytic step can reach 90% or higher. The equation itself becomes the design constraint.
Green chemistry shifts the design question from "How do we remove the waste?" to "How do we ensure it never forms?" by maximising atom economy, choosing catalytic over stoichiometric pathways, and minimising synthetic steps.